Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR and sequencing, enabling biomarker research, target validation, and more informed development decisions.

Market research shouldn’t lag behind decisions. With AI, organizations can transform it into a sensing engine, continuously capturing signals, connecting data across studies and delivering real-time insights to drive faster, sharper commercial decisions.

Artificial intelligence is transforming pharma, but success depends on more than powerful algorithms. Download this whitepaper to learn how leading organizations are building content, governance, and licensing strategies that reduce risk, support compliance, and enable AI at scale.

Explore how continuous manufacturing strategies can support more scalable, efficient, and cost-effective mAb production. Download this free whitepaper for insights into process integration, regulatory considerations, and long-term biologics manufacturing success.

Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report examines key trends, gaps in care, and how data and digital strategies are evolving to meet new expectations. Download the report to learn more.

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical development, commercial strategy, patient insights, and post-market evaluation.